Company / Operating Income per Share
ROCKET PHARMACEUTICALS, INC. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.57
FY2025
5-year range
-$2.57 / -$1.25
FY2021-FY2025
Trend
-3.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has declined for 4 consecutive years, from $-1.25 in FY2021 to $-2.57 in FY2025.
Based on SEC 10-K filings.
-2.57 in FY2025.
Declined from $-2.11 to $-2.57 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s operating income per share has declined for 4 consecutive years.
- In FY2025, operating income per share decreased 3.3% year-over-year.
- Peak operating income per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.57 | -3.3% |
| FY2024 | -$2.48 | -17.6% |
| FY2023 | -$2.11 | -1.5% |
| FY2022 | -$2.08 | -66.8% |
| FY2021 | -$1.25 | +3.9% |
| FY2020 | -$1.30 | +17.6% |
| FY2019 | -$1.58 | -41.4% |
| FY2018 | -$1.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026